TNF-derived peptides for use in treating oedema

Peptides TNF-dérivés pour le traitement des oedémes

TNF-Peptide und deren Verwendung zur Behandlung von Ödemen


The present invention relates to the finding that peptides derived from a specific domain of tumor necrosis factor-alpha (TNF-α) can efficiently be used to treat oedema. More specifically, the present invention relates to the usage of peptides derived from the region of human TNF-α from Ser 100 to Glu 116 to treat pulmonary oedema. Moreover, the present invention concerns a circularized peptide having amino acid sequence CGQRETPEGAEAKPWYC which is very efficient in inducing oedema resolution.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (2)

    Publication numberPublication dateAssigneeTitle
    DE-3841759-A1June 13, 1990Basf AgNeue tnf-peptide
    WO-9418325-A1August 18, 1994N.V. Innogenetics S.A.Tnf-alpha muteins and a process for preparing them

NO-Patent Citations (1)

    LUCAS R ET AL: "Mapping the lectin-like activity of tumor necrosis factor", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 263, 11 February 1994 (1994-02-11), pages 814 - 817, XP002094772, ISSN: 0036-8075

Cited By (7)

    Publication numberPublication dateAssigneeTitle
    CN-102355906-AFebruary 15, 2012阿佩普蒂科研究和开发有限责任公司预防和治疗高渗透性的方法
    EP-2397151-A1December 21, 2011Apeptico Forschung Und Entwicklung GmbhBehandlung vaskulärer Komplikationen von Diabetes
    US-7258861-B2August 21, 2007Innogenetics N.V.TNF-derived peptides for use in treating oedema
    US-9359419-B2June 07, 2016Apeptico Forschung Und Entwicklung GmbhTreatment of vascular complications of diabetes
    WO-2010099556-A1September 10, 2010Apeptico Forschung Und Entwicklung GmbhVerfahren zur vermeidung und zur behandlung einer hyperpermeabilität
    WO-2011160664-A1December 29, 2011Apeptico Forschung Und Entwicklung GmbhTraitement de complications vasculaires du diabète
    WO-2012065201-A1May 24, 2012Apeptico Forschung Und Entwicklung GmbhComposition comprenant un peptide et un inhibiteur de la neuraminidase virale